Physician

Theerapol Prasertsuntarasai, MD

According to 2025 Medicare claims, Theerapol Prasertsuntarasai, MD (NPI: 1245373380) practices rheumatology in the Lubbock, TX market, with the plurality of this provider's patient population coming from Lubbock, TX. This provider's primary affiliated billing organization is THEERAPOL PRASERTSUNTARASAI MD PA (NPI: 1659956308; TIN: 843960594) and primary practice location at 79424-6985. Prasertsuntarasai is affiliated with the Covenant ACO, Inc. (ACO ID: A2021), Main Street Rural Health Sycamore ACO LLC (ACO ID: A5403), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Prasertsuntarasai's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 263 traditional Medicare patients, billed 110,528 HCPCS/CPT codes, and received $2,157,776 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 2,803 prescription claims across 366 beneficiaries totaling $1,382,163 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 105 records totaling $2,021. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,587,253 and ending at $2,157,776. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $748,464 and ending at $1,382,163. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	436	78,493	$1,587,253
2016	471	73,665	$1,873,435
2017	439	35,945	$1,310,770
2018	150	16,106	$476,267
2019	184	28,624	$922,227
2020	194	36,197	$1,180,028
2021	195	26,596	$752,169
2022	243	37,321	$1,069,019
2023	250	60,546	$1,420,038
2024	263	110,528	$2,157,776

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	394	3,231	$748,464
2016	440	4,094	$1,111,831
2017	398	2,816	$890,507
2018	145	713	$195,804
2019	168	1,393	$667,202
2020	172	1,559	$795,153
2021	180	1,338	$797,375
2022	259	2,057	$509,729
2023	338	2,606	$828,463
2024	366	2,803	$1,382,163

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	132	639	$95
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	160	244	$86
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	193	425	$60
96415	Administration of chemotherapy into vein, each additional hour	108	684	$21
96372	Injection of drug or substance under skin or into muscle	101	177	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Enbrel Sureclick	Etanercept	45	1,260	$352,396
Orencia Clickject	Abatacept	33	924	$201,141
Humira(Cf) Pen	Adalimumab	26	728	$179,078
Benlysta	Belimumab	21	644	$116,127
Xeljanz Xr	Tofacitinib Citrate	16	480	$98,593

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	105	$2,021	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Theerapol Prasertsuntarasai, MD?

Tedicare shows public-source Medicare data for Theerapol Prasertsuntarasai, MD (NPI 1245373380), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Theerapol Prasertsuntarasai, MD have ACO affiliation data?

Theerapol Prasertsuntarasai, MD is shown with ACO affiliation data for Covenant ACO, Inc. (MSSP, ACO ID A2021), Main Street Rural Health Sycamore ACO LLC (MSSP, ACO ID A5403), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Theerapol Prasertsuntarasai, MD?

Theerapol Prasertsuntarasai, MD is linked to THEERAPOL PRASERTSUNTARASAI MD PA (billing NPI 1659956308) in the available physician profile data.

Does Theerapol Prasertsuntarasai, MD have Open Payments data?

Theerapol Prasertsuntarasai, MD has 105 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.